Dick Chan

Dick Chan is a Senior Research Fellow at the University of Western Australia's UWA Medical School, specializing in Internal Medicine. With a PhD from UWA (2002), he has secured over $4.5M in research funding from NHMRC, NHF, and industry partners like Amgen and Merck.

• BSc, MPhil, PhD (University of Western Australia)

His research focuses on lipoprotein metabolism and cardiovascular disease, particularly examining lipid disorders, visceral obesity, metabolic syndrome, and familial hypercholesterolemia. His kinetic studies on drug interventions like statins and omega-3 fatty acids have gained international recognition.

Recent publications analyze cardiovascular risk stratification in familial hypercholesterolemia, arterial inflammation post-COVID-19, and phytosterolaemia detection. His work contributes to UN Sustainable Development Goals related to health and well-being.

Scientific Awards

• 2010: Royal College of Pathology Fellowship (UK)
• 2008: International Society of Atherosclerosis Visiting Fellowship
• 2003-2012: Competitive Research Fellowships (NHF, NHMRC)

Dick mentors junior academics and supervises graduate students. He serves on NHMRC grant panels and contributes to FH clinical programs in Australia.